Sarepta Therapeutics
SRPT
#2370
Rank
โ‚น519.69 B
Marketcap
โ‚น5,356
Share price
0.90%
Change (1 day)
-49.40%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -โ‚น644.14

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น671.31. In 2022 the company made an earnings per share (EPS) of -โ‚น688.46 a decrease over its 2021 EPS that were of -โ‚น441.54.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น644.14-6.44%
2022-โ‚น688.4655.92%
2021-โ‚น441.54-27.16%
2020-โ‚น606.15-26.96%
2019-โ‚น829.9278.6%
2018-โ‚น464.69603.9%
2017-โ‚น66.02-85.9%
2016-โ‚น468.125.2%
2015-โ‚น444.9753.1%
2014-โ‚น290.65-0%
2013-โ‚น290.65-33.79%
2012-โ‚น438.977214.29%
2011-โ‚น6.00-96.11%
2010-โ‚น154.3215.38%
2009-โ‚น133.75-23.53%
2008-โ‚น174.90-37.04%
2007-โ‚น277.78-0%
2006-โ‚น277.7845.95%
2005-โ‚น190.33-46.38%
2004-โ‚น354.9540.82%
2003-โ‚น252.06-57.02%
2002-โ‚น586.43-2.56%
2001-โ‚น601.87138.78%
2000-โ‚น252.06-20.97%
1999-โ‚น318.94-72.2%
1998-โ‚น1,147519.44%
1997-โ‚น185.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น376.38-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น616.44-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น265.78-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น107.17-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น352.37-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น741.62 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น451.83-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA